SEARCH

SEARCH BY CITATION

References

  • 1
    Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981999.
  • 2
    Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74: 427437.
  • 3
    Vosnides GG. Nephrology Forum: hepatitis C in renal transplantation. Kidney Int 1997; 52: 843861.
  • 4
    Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 14521461.
  • 5
    Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 65: 667670.
  • 6
    Hanafusa T, Ichikawa Y, Kishikawa H et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471476.
  • 7
    Cruzado JM, Carrera M, Torras J, Grinyo JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1: 171178.
  • 8
    Hestin D, Guillemin F, Castin N, Le Faout A, Champignulles J, Kessler M. Pretransplant hepatitis C virus infection. A predictor of proteinuria after renal transplantation. Transplantation 1998; 65: 741744.
  • 9
    Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 2002; 25: 583592.
  • 10
    Miles AMV, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation. As deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380384.
  • 11
    Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 8994.
  • 12
    Mason AL, Lau JYN, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328333.
  • 13
    Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 10591063.
  • 14
    Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592599.
  • 15
    AlDosary AA, Ramji AS, Elliott TG et al. Post-liver transplantation diabetes mellitus: an association with hepatitis C. Liver Transpl 2002; 8: 356361.
  • 16
    Baid S, Cosimi AB, Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 10661072.
  • 17
    Khalili M, Lim WJ, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004; 10: 349355.
  • 18
    Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998; 26: 3034.
  • 19
    Batty DS, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001; 1: 179184.
  • 20
    Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005; 5: 139144.
  • 21
    Poynard T, Conn HO. The retrieval of randomised clinical trials in liver diseases from the medical literature: a comparison of MEDLARS and manual methods. Control Clin Trials 1985; 6: 271279.
  • 22
    The American Diabetes Association Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998; 21(Suppl. 1): 58.
  • 23
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177188.
  • 24
    Gursoy M, Guvener N, Koksal R et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients. Transplant Proc 2000; 32: 561562.
  • 25
    Yildiz A, Tutuncu Y, Yazici H et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation 2002; 74: 11091113.
  • 26
    Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. Am J Soc Nephrol 2002; 13: 13741380.
  • 27
    Gentil MA, Luna E, Rodriguez-Algarra G et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17: 887891.
  • 28
    Gentil MA, Lopez M, Gonzalez-Roncero F et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols. Transplant Proc 2003; 35: 17481750.
  • 29
    Finni PES, Souza ERM, Rioja S et al. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus ? Transplant Proc 2004; 36: 884885.
  • 30
    Foo SM, Wong HS, Morad Z. Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc 2004; 36: 21392140.
  • 31
    Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant 2004; 4: 18761882.
  • 32
    Sens YAS, Silva VDST, Malafronte P, Souza JF, Miorin LA, Jabur P. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. Transplant Proc 2004; 36: 886888.
  • 33
    Gentil MA, Rocha JL, Pereira P, Algarra GR, Lopez R. High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C (letter). Nephron 1999; 82: 85.
  • 34
    Younossi ZM, Braun WE, Protiva DA, Gifford RW, Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning more than 20 years. Transplantation 1999; 67: 272275.
  • 35
    Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178185.
  • 36
    Abbott KC, Lentine KL, Bucci JR et al. Impact of diabetes and hepatitis after kidney transplantation in patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004; 15: 31663174.
  • 37
    Soma J, Saito T, Taguma Y et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 2000; 11: 690699.
  • 38
    Saxena AK, Panhotra BR. The susceptibility of patient with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly 2003; 133: 611618.
  • 39
    Miller J, Mendez R, Pirsch JD, Jensik SC. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil in cadaveric renal transplant recipients. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. Transplantation 2000; 69: 875880.
  • 40
    Ahsan N, Johnson C, Gonwa T et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation 2001; 72: 245250.
  • 41
    Margreiter A. A prospective, randomized multicentre study to compare the efficacy and safety of tacrolimus and cyclosporin microemulsion in renal transplantation. Transplantation 2000; 69: 112.
  • 42
    Baid S, Tolkoff-Rubin N, Farrell ML et al. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplant Proc 2002; 34: 17711773.
  • 43
    Kamar N, Toupance O, Buchler M et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 2003; 14: 20922098.
  • 44
    Khan KS, Daya S, Jadad AR. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996; 156: 661666.
  • 45
    Konrad T, Zeuzem S, Vicini P et al. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interpheron alpha. Eur J Clin Invest 2000; 30: 111121.
  • 46
    Delgado-Borrego A, Casson D, Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004; 77: 703710.
  • 47
    Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 2004; 41: 132138.
  • 48
    Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840848.
  • 49
    Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/P13-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 13841392.
  • 50
    Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165: 14991508.
  • 51
    Laskus T, Radkowski M, Wang L, Vargas H, Rakela J. Search for hepatitis C virus replication sites in patients with acquired immune deficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998; 28: 13981401.
  • 52
    Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000; 32: 209214.
  • 53
    Muzzi A, Leandro G, Rubbia-Brandt L et al. and the Swiss Hepatitis C Cohort Study. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 2005; 42: 4146.
  • 54
    Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533539.
  • 55
    Romero-Gomez M, Del Mar Viloria M, Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128: 636641.